PALIPERIDONE PALMITATE

PALIPERIDONE PALMITATE was reported 32681 times

PALIPERIDONE PALMITATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD PROLACTIN ABNORMAL 292 0.3384
1 ANOSOGNOSIA 214 0.2786
2 BLOOD PROLACTIN INCREASED 954 0.2021
3 ENTERITIS NECROTICANS 6 0.1667
4 PSYCHOSEXUAL DISORDER 42 0.1453
5 ALEXITHYMIA 7 0.1400
6 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 17 0.1360
7 GALACTORRHOEA 706 0.1098
8 DISTURBANCE IN SOCIAL BEHAVIOUR 258 0.1094
9 PSYCHOTIC SYMPTOM 217 0.1050
10 SCHIZOAFFECTIVE DISORDER 175 0.0980
11 SCHIZOPHRENIA 1151 0.0946
12 SACCADIC EYE MOVEMENT 15 0.0898
13 CAFFEINE CONSUMPTION 6 0.0870
14 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 18 0.0783
15 BOREDOM 22 0.0649
16 BREAST DISCHARGE 108 0.0616
17 BLUNTED AFFECT 42 0.0569
18 HYPERPROLACTINAEMIA 367 0.0566
19 PROLACTIN-PRODUCING PITUITARY TUMOUR 11 0.0558
20 REFUSAL OF TREATMENT BY PATIENT 355 0.0543
21 METAMYELOCYTE COUNT INCREASED 8 0.0537
22 MYELOCYTE COUNT INCREASED 10 0.0532
23 POOR PERSONAL HYGIENE 27 0.0523
24 SOLILOQUY 44 0.0509
25 LACTATION DISORDER 24 0.0493
26 INJECTION SITE NODULE 521 0.0473
27 EXPOSURE TO CONTAMINATED DEVICE 12 0.0456
28 RETROGRADE EJACULATION 36 0.0454
29 INJECTION SITE CYST 13 0.0444
30 HALLUCINATION, AUDITORY 685 0.0431
31 IMPRISONMENT 75 0.0424
32 SCHIZOPHRENIFORM DISORDER 10 0.0412
33 BREAST ENGORGEMENT 12 0.0405
34 METABOLIC DISORDER 233 0.0401
35 AKATHISIA 527 0.0386
36 NEGLECT OF PERSONAL APPEARANCE 9 0.0370
37 SHOULDER DEFORMITY 7 0.0354
38 GYNAECOMASTIA 1085 0.0350
39 EXTRAOCULAR MUSCLE PARESIS 16 0.0349
40 SPERMATOZOA ABNORMAL 9 0.0342
41 SEXUAL DYSFUNCTION 388 0.0331
42 DROOLING 223 0.0322
43 EMOTIONAL POVERTY 55 0.0314
44 BREAST ENLARGEMENT 102 0.0311
45 FLAT AFFECT 72 0.0311
46 PSYCHOTIC DISORDER 916 0.0310
47 PATIENT ELOPEMENT 11 0.0301
48 HYPERMETABOLISM 15 0.0283
49 ABNORMAL WEIGHT GAIN 331 0.0268
50 MALIGNANT CATATONIA 7 0.0266
51 WITHDRAWAL CATATONIA 6 0.0260
52 STEREOTYPY 24 0.0255
53 DELUSION 387 0.0249
54 PARANOIA 408 0.0236
55 AMENORRHOEA 412 0.0235
56 PERSONALITY CHANGE 213 0.0229
57 OCULOGYRIC CRISIS 49 0.0228
58 SCHIZOPHRENIA, PARANOID TYPE 8 0.0222
59 PITUITARY TUMOUR 32 0.0214
60 DYSTONIA 415 0.0214
61 SYRINGE ISSUE 371 0.0212
62 EJACULATION FAILURE 42 0.0209
63 ABULIA 19 0.0205
64 PERSECUTORY DELUSION 51 0.0204
65 TOBACCO USER 30 0.0202
66 NEUROLEPTIC MALIGNANT SYNDROME 234 0.0197
67 INJECTION SITE ABSCESS 49 0.0197
68 SEDATION 502 0.0191
69 EXTRAPYRAMIDAL DISORDER 471 0.0189
70 PSYCHIATRIC DECOMPENSATION 37 0.0189
71 CATATONIA 97 0.0185
72 BLOOD OSMOLARITY DECREASED 11 0.0176
73 TREATMENT NONCOMPLIANCE 962 0.0176
74 SUBSTANCE USE 27 0.0173
75 PROSTATIC PAIN 7 0.0172
76 ORTHOSTATIC HYPERTENSION 10 0.0172
77 PROTRUSION TONGUE 10 0.0172
78 ANTISOCIAL BEHAVIOUR 17 0.0170
79 PRESSURE OF SPEECH 11 0.0169
80 GRANDIOSITY 6 0.0164
81 HOMICIDAL IDEATION 66 0.0163
82 PRODUCT LEAKAGE 91 0.0162
83 HALLUCINATION, OLFACTORY 7 0.0161
84 BODY DYSMORPHIC DISORDER 6 0.0160
85 PARKINSONISM 151 0.0155
86 INFERTILITY 23 0.0153
87 TONGUE MOVEMENT DISTURBANCE 13 0.0152
88 DERMO-HYPODERMITIS 9 0.0151
89 MALE SEXUAL DYSFUNCTION 9 0.0150
90 MASKED FACIES 6 0.0148
91 SEDATION COMPLICATION 37 0.0145
92 PRODUCT OUTER PACKAGING ISSUE 13 0.0144
93 PHYSICAL ASSAULT 30 0.0143
94 SOCIAL AVOIDANT BEHAVIOUR 83 0.0143
95 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 11 0.0141
96 PITUITARY TUMOUR BENIGN 23 0.0141
97 INVESTIGATION 44 0.0140
98 BELLIGERENCE 6 0.0140
99 EYE MOVEMENT DISORDER 95 0.0139
100 LIBIDO DISORDER 18 0.0138
101 WATER INTOXICATION 7 0.0138
102 FEELING GUILTY 18 0.0136
103 THOUGHT BLOCKING 8 0.0136
104 PRIAPISM 47 0.0136
105 MANIA 223 0.0135
106 INFERTILITY MALE 6 0.0133
107 INJECTION SITE CELLULITIS 24 0.0129
108 PSYCHOTIC BEHAVIOUR 13 0.0128
109 THERAPEUTIC RESPONSE INCREASED 12 0.0128
110 THERAPEUTIC RESPONSE DECREASED 767 0.0126
111 PRODUCT CONTAINER SEAL ISSUE 22 0.0126
112 IMPAIRED SELF-CARE 26 0.0125
113 LANGUAGE DISORDER 27 0.0125
114 COGWHEEL RIGIDITY 13 0.0124
115 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 11 0.0124
116 DIET REFUSAL 9 0.0123
117 SELF-MEDICATION 50 0.0122
118 ANORGASMIA 33 0.0121
119 HOSPITALISATION 1836 0.0119
120 TARDIVE DYSKINESIA 336 0.0119
121 REDUCED FACIAL EXPRESSION 12 0.0118
122 LIVING IN RESIDENTIAL INSTITUTION 22 0.0117
123 INJECTION SITE ULCER 11 0.0117
124 ERECTILE DYSFUNCTION 299 0.0116
125 DYSKINESIA 473 0.0116
126 OBESITY 184 0.0115
127 MUSCLE RIGIDITY 136 0.0114
128 INAPPROPRIATE AFFECT 18 0.0113
129 ACUTE PSYCHOSIS 28 0.0113
130 DRUG LEVEL ABNORMAL 6 0.0113
131 HALLUCINATIONS, MIXED 47 0.0112
132 STARING 27 0.0112
133 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 785 0.0110
134 ABNORMAL BEHAVIOUR 429 0.0108
135 EJACULATION DELAYED 6 0.0108
136 EJACULATION DISORDER 30 0.0106
137 HALLUCINATION, TACTILE 7 0.0105
138 SELF-DESTRUCTIVE BEHAVIOUR 9 0.0103
139 APATHY 150 0.0103
140 HOSTILITY 26 0.0102
141 INJECTION SITE MASS 378 0.0102
142 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 7 0.0101
143 SLOW RESPONSE TO STIMULI 13 0.0100
144 LOSS OF LIBIDO 90 0.0100
145 SUSPICIOUSNESS 7 0.0100
146 METABOLIC SYNDROME 16 0.0097
147 INJECTION SITE INFECTION 32 0.0097
148 AGGRESSION 485 0.0097
149 OROMANDIBULAR DYSTONIA 7 0.0096
150 SUBSTANCE ABUSE 76 0.0093
151 SALIVARY HYPERSECRETION 93 0.0093
152 POST-INJECTION DELIRIUM SEDATION SYNDROME 8 0.0093
153 LOGORRHOEA 32 0.0091
154 NEEDLE ISSUE 263 0.0090
155 OVERWEIGHT 48 0.0089
156 DILATED CARDIOMYOPATHY 9 0.0089
157 PLEUROTHOTONUS 8 0.0088
158 THINKING ABNORMAL 164 0.0088
159 EXCESSIVE EYE BLINKING 13 0.0088
160 INCORRECT STORAGE OF DRUG 15 0.0087
161 HYPERAMMONAEMIC ENCEPHALOPATHY 15 0.0086
162 RESTLESSNESS 315 0.0086
163 BLAST CELL COUNT INCREASED 9 0.0086
164 DRUG DOSE OMISSION 1417 0.0086
165 ANTIPSYCHOTIC DRUG LEVEL INCREASED 24 0.0085
166 TACHYPHRENIA 29 0.0084
167 OBSESSIVE THOUGHTS 15 0.0083
168 BIPOLAR DISORDER 90 0.0083
169 SYPHILIS 6 0.0083
170 BIPOLAR I DISORDER 18 0.0082
171 HOMICIDE 15 0.0081
172 EMOTIONAL DISORDER 251 0.0081
173 HYPERTHERMIA MALIGNANT 12 0.0081
174 TORTICOLLIS 17 0.0080
175 TRISMUS 41 0.0079
176 BRUXISM 41 0.0076
177 WEIGHT INCREASED 1699 0.0076
178 JUDGEMENT IMPAIRED 11 0.0076
179 ANION GAP INCREASED 10 0.0075
180 BREAST TENDERNESS 56 0.0074
181 ORGASM ABNORMAL 6 0.0074
182 BINGE EATING 8 0.0074
183 LIBIDO INCREASED 15 0.0074
184 FACIAL ASYMMETRY 7 0.0073
185 HYPERPHAGIA 29 0.0073
186 WRONG PRODUCT ADMINISTERED 48 0.0071
187 INCOHERENT 45 0.0069
188 PRODUCT PACKAGING ISSUE 66 0.0069
189 NONSPECIFIC REACTION 38 0.0069
190 PSYCHIATRIC SYMPTOM 51 0.0069
191 MUSCLE CONTRACTURE 14 0.0069
192 PERSONALITY DISORDER 18 0.0069
193 DRUG EFFECT DECREASED 368 0.0068
194 DRUG ADMINISTERED AT INAPPROPRIATE SITE 70 0.0066
195 PSYCHOMOTOR SKILLS IMPAIRED 17 0.0065
196 VIOLENCE-RELATED SYMPTOM 10 0.0065
197 MEGACOLON 10 0.0064
198 PENILE SIZE REDUCED 6 0.0063
199 MENTAL IMPAIRMENT 152 0.0063
200 SUICIDE ATTEMPT 378 0.0062
201 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 114 0.0062
202 MUTISM 9 0.0062
203 MOANING 7 0.0062
204 IMPULSIVE BEHAVIOUR 23 0.0061
205 BEHAVIOUR DISORDER 33 0.0061
206 THERAPEUTIC PRODUCT EFFECT DECREASED 273 0.0061
207 ILLUSION 10 0.0060
208 COMMUNICATION DISORDER 23 0.0060
209 ALCOHOL ABUSE 16 0.0060
210 ALCOHOL USE 22 0.0060
211 INTRUSIVE THOUGHTS 7 0.0059
212 UNDERDOSE 434 0.0059
213 ENURESIS 24 0.0059
214 DECREASED INTEREST 35 0.0059
215 LAZINESS 10 0.0059
216 PRODUCT DOSE OMISSION 381 0.0058
217 PHYSICAL DECONDITIONING 15 0.0058
218 POLYDIPSIA 23 0.0058
219 ADVERSE EVENT 533 0.0058
220 SLOW SPEECH 14 0.0058
221 HYPERSOMNIA 164 0.0057
222 BLOOD TESTOSTERONE DECREASED 39 0.0057
223 HALLUCINATION 425 0.0056
224 EMERGENCY CARE 17 0.0056
225 UNDERWEIGHT 11 0.0056
226 PRODUCT ADMINISTRATION ERROR 112 0.0055
227 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 93 0.0054
228 DRUG SCREEN FALSE POSITIVE 15 0.0054
229 BREAST DISORDER 11 0.0054
230 INCREASED APPETITE 103 0.0054
231 MUSCLE TWITCHING 124 0.0054
232 SOCIAL PROBLEM 22 0.0053
233 BLOOD BICARBONATE DECREASED 10 0.0053
234 BODY TEMPERATURE FLUCTUATION 11 0.0053
235 SUICIDAL IDEATION 481 0.0052
236 BRADYKINESIA 31 0.0052
237 DRUG SCREEN POSITIVE 41 0.0052
238 AGITATION 379 0.0052
239 LACK OF INJECTION SITE ROTATION 9 0.0051
240 ACCIDENTAL EXPOSURE 21 0.0050
241 HYPOKINESIA 73 0.0050
242 SCREAMING 32 0.0050
243 PRODUCT DOSE OMISSION ISSUE 1460 0.0050
244 INJECTION SITE INDURATION 64 0.0049
245 SKULL FRACTURE 8 0.0049
246 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 11 0.0049
247 SELF INJURIOUS BEHAVIOUR 15 0.0049
248 INJECTION SITE HYPOAESTHESIA 7 0.0049
249 BREAST SWELLING 13 0.0048
250 GAMBLING DISORDER 13 0.0048
251 NEGATIVE THOUGHTS 14 0.0048
252 INTELLECTUAL DISABILITY 7 0.0046
253 POSTURE ABNORMAL 15 0.0046
254 WRONG DRUG ADMINISTERED 41 0.0046
255 ADVERSE DRUG REACTION 413 0.0046
256 PROTEIN TOTAL INCREASED 12 0.0045
257 DEVICE OCCLUSION 63 0.0045
258 CARDIAC DISCOMFORT 9 0.0045
259 LIPIDS INCREASED 9 0.0045
260 MENTAL DISORDER 191 0.0044
261 HYPERSEXUALITY 8 0.0044
262 SINUS NODE DYSFUNCTION 8 0.0044
263 AKINESIA 9 0.0043
264 DISORGANISED SPEECH 8 0.0043
265 DEVICE LEAKAGE 188 0.0043
266 SLUGGISHNESS 44 0.0043
267 LOSS OF EMPLOYMENT 13 0.0043
268 PRODUCT LABEL ISSUE 29 0.0043
269 IMPATIENCE 8 0.0043
270 MASTICATION DISORDER 13 0.0042
271 GLUCOSE TOLERANCE IMPAIRED 25 0.0042
272 INTENSIVE CARE 6 0.0042
273 LIP DISORDER 8 0.0042
274 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 741 0.0041
275 BREATH ODOUR 10 0.0041
276 BICYTOPENIA 8 0.0041
277 HYPOMANIA 15 0.0041
278 INJECTION SITE OEDEMA 7 0.0041
279 INSURANCE ISSUE 61 0.0040
280 OBSESSIVE-COMPULSIVE DISORDER 32 0.0040
281 OFF LABEL USE 3485 0.0040
282 COMPULSIVE SHOPPING 8 0.0039
283 INCORRECT DOSE ADMINISTERED 886 0.0039
284 ANGER 131 0.0039
285 INJECTION SITE SCAR 11 0.0039
286 INFERTILITY FEMALE 6 0.0039
287 LIQUID PRODUCT PHYSICAL ISSUE 28 0.0038
288 INJECTION SITE INFLAMMATION 19 0.0038
289 SELF-INJURIOUS IDEATION 16 0.0038
290 PROCEDURAL COMPLICATION 29 0.0038
291 INJECTION SITE REACTION 259 0.0038
292 INTENTIONAL SELF-INJURY 76 0.0038
293 DRUG ADMINISTRATION ERROR 114 0.0037
294 EATING DISORDER 79 0.0037
295 MAJOR DEPRESSION 27 0.0037
296 INCONTINENCE 39 0.0037
297 HORMONE LEVEL ABNORMAL 18 0.0037
298 BRADYPHRENIA 24 0.0037
299 DYSPHEMIA 16 0.0036
300 INJECTION SITE EXTRAVASATION 45 0.0036
301 FEELING OF DESPAIR 17 0.0036
302 SINUS TACHYCARDIA 51 0.0036
303 SUDDEN DEATH 38 0.0036
304 BRAIN INJURY 36 0.0036
305 ANHEDONIA 93 0.0035
306 GAZE PALSY 6 0.0035
307 BLOOD PH DECREASED 6 0.0035
308 READING DISORDER 8 0.0035
309 POST-TRAUMATIC STRESS DISORDER 23 0.0034
310 AFFECT LABILITY 33 0.0034
311 STUPOR 11 0.0034
312 DISABILITY 67 0.0034
313 CEREBRAL DISORDER 25 0.0034
314 HALLUCINATION, VISUAL 71 0.0034
315 DELIRIUM 116 0.0033
316 PRODUCT TAMPERING 6 0.0033
317 MOTOR DYSFUNCTION 34 0.0033
318 MYOCARDITIS 38 0.0033
319 TIC 18 0.0033
320 FOETAL DISTRESS SYNDROME 7 0.0033
321 CLUMSINESS 9 0.0033
322 IRRITABILITY 198 0.0033
323 CONDITION AGGRAVATED 996 0.0033
324 INCORRECT PRODUCT STORAGE 43 0.0033
325 DEREALISATION 7 0.0033
326 PSYCHOMOTOR HYPERACTIVITY 54 0.0033
327 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
328 TREMOR 537 0.0032
329 ABNORMAL LOSS OF WEIGHT 22 0.0032
330 DIABETIC COMA 9 0.0032
331 AFFECTIVE DISORDER 25 0.0032
332 DRUG PRESCRIBING ERROR 61 0.0032
333 SUICIDAL BEHAVIOUR 13 0.0031
334 PRODUCT PRESCRIBING ERROR 74 0.0031
335 COGNITIVE DISORDER 145 0.0031
336 ORTHOSTATIC HYPOTENSION 54 0.0031
337 AUTISM SPECTRUM DISORDER 17 0.0031
338 MUSCULOSKELETAL STIFFNESS 269 0.0031
339 HEPATIC NEOPLASM 10 0.0031
340 ALCOHOLISM 13 0.0030
341 DIPLEGIA 6 0.0030
342 NEAR DEATH EXPERIENCE 10 0.0030
343 SPEECH DISORDER 158 0.0030
344 SKIN MASS 20 0.0030
345 NIPPLE PAIN 6 0.0029
346 FEAR OF INJECTION 21 0.0029
347 IMPULSE-CONTROL DISORDER 6 0.0029
348 NODULE 38 0.0029
349 PRODUCT STORAGE ISSUE 11 0.0029
350 RESTLESS LEGS SYNDROME 52 0.0029
351 DRUG TOLERANCE DECREASED 8 0.0028
352 PSYCHOMOTOR RETARDATION 8 0.0028
353 REHABILITATION THERAPY 11 0.0028
354 BREAST MASS 19 0.0028
355 RHABDOMYOLYSIS 116 0.0028
356 URINARY INCONTINENCE 82 0.0028
357 DYSARTHRIA 104 0.0028
358 DISTURBANCE IN ATTENTION 149 0.0028
359 TENDON DISORDER 18 0.0028
360 IMMOBILE 12 0.0027
361 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8 0.0027
362 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 28 0.0027
363 DEPRESSION 619 0.0027
364 BLOOD TRIGLYCERIDES INCREASED 48 0.0027
365 FEAR 73 0.0027
366 BLOOD CREATINE PHOSPHOKINASE INCREASED 78 0.0027
367 BLEPHAROSPASM 17 0.0027
368 URINE OUTPUT INCREASED 7 0.0027
369 ANAL INCONTINENCE 24 0.0027
370 BEDRIDDEN 35 0.0027
371 DRUG LEVEL DECREASED 27 0.0027
372 PRODUCT USE IN UNAPPROVED INDICATION 653 0.0026
373 DRUG ABUSE 218 0.0026
374 DRUG LEVEL INCREASED 43 0.0026
375 MEDICATION ERROR 144 0.0026
376 LETHARGY 148 0.0026
377 HYPOTHERMIA 26 0.0026
378 ASPIRATION 28 0.0026
379 MOVEMENT DISORDER 82 0.0026
380 DRUG DELIVERY SYSTEM MALFUNCTION 13 0.0025
381 SOMNOLENCE 504 0.0025
382 TROPONIN INCREASED 19 0.0025
383 MUSCLE DISORDER 20 0.0025
384 TENSION 15 0.0025
385 BREAST PAIN 26 0.0024
386 INSOMNIA 647 0.0024
387 INJECTION SITE SWELLING 186 0.0024
388 PRODUCT USE ISSUE 456 0.0024
389 INJECTION SITE DISCHARGE 13 0.0024
390 MENSTRUAL DISORDER 20 0.0024
391 WRONG PATIENT RECEIVED PRODUCT 7 0.0024
392 COMPLETED SUICIDE 199 0.0024
393 DYSPHORIA 12 0.0024
394 EUPHORIC MOOD 24 0.0023
395 PRODUCT TEMPERATURE EXCURSION ISSUE 12 0.0023
396 POOR QUALITY DRUG ADMINISTERED 15 0.0023
397 INJECTION SITE PAIN 709 0.0023
398 DEPRESSION SUICIDAL 8 0.0023
399 ATRIOVENTRICULAR BLOCK FIRST DEGREE 10 0.0023
400 PARALYSIS 33 0.0023
401 HUNGER 32 0.0023
402 IMPAIRED WORK ABILITY 49 0.0023
403 INJECTION SITE DISCOMFORT 24 0.0023
404 INJECTION SITE RASH 70 0.0023
405 PHYSICAL DISABILITY 10 0.0023
406 NERVE INJURY 25 0.0022
407 ALCOHOL POISONING 6 0.0022
408 INCORRECT ROUTE OF DRUG ADMINISTRATION 80 0.0022
409 HYPERTHERMIA 17 0.0022
410 SWOLLEN TONGUE 69 0.0022
411 SENSORY DISTURBANCE 35 0.0022
412 ACCIDENTAL EXPOSURE TO PRODUCT 224 0.0022
413 PRODUCT PHYSICAL CONSISTENCY ISSUE 12 0.0022
414 ERECTION INCREASED 9 0.0021
415 MUSCLE ATROPHY 27 0.0021
416 GRANULOCYTOPENIA 12 0.0021
417 ANXIETY 598 0.0021
418 MUSCLE TIGHTNESS 34 0.0021
419 HYPERTONIA 12 0.0021
420 DISSOCIATION 16 0.0021
421 MONOPLEGIA 9 0.0021
422 THIRST 37 0.0021
423 PANIC DISORDER 8 0.0021
424 FEELING ABNORMAL 493 0.0021
425 NIGHTMARE 71 0.0020
426 POOR QUALITY SLEEP 44 0.0020
427 STRABISMUS 6 0.0020
428 THERAPY CHANGE 20 0.0020
429 SKIN ODOUR ABNORMAL 8 0.0020
430 CARDIAC FLUTTER 13 0.0020
431 SYMPTOM RECURRENCE 12 0.0020
432 DEPRESSIVE SYMPTOM 7 0.0020
433 DYSLIPIDAEMIA 10 0.0020
434 EXPIRED PRODUCT ADMINISTERED 65 0.0020
435 TONGUE DISORDER 14 0.0019
436 UMBILICAL HERNIA 9 0.0019
437 HEAD DISCOMFORT 34 0.0019
438 TORSADE DE POINTES 15 0.0019
439 POISONING 24 0.0019
440 PARADOXICAL DRUG REACTION 7 0.0019
441 TACHYCARDIA 167 0.0019
442 DEPRESSED MOOD 99 0.0019
443 PRODUCT QUALITY ISSUE 254 0.0019
444 APHASIA 56 0.0019
445 BRAIN FOG 29 0.0018
446 ASPHYXIA 15 0.0018
447 DEVICE MALFUNCTION 129 0.0018
448 DRUG LEVEL BELOW THERAPEUTIC 10 0.0018
449 APPETITE DISORDER 12 0.0018
450 THERAPEUTIC RESPONSE SHORTENED 60 0.0018
451 SEIZURE 206 0.0018
452 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
453 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 85 0.0018
454 FACIAL PARALYSIS 15 0.0018
455 MEDICAL DEVICE COMPLICATION 13 0.0018
456 PRODUCT COLOUR ISSUE 9 0.0018
457 EAR DISORDER 8 0.0017
458 VIITH NERVE PARALYSIS 6 0.0017
459 HYPOPNOEA 6 0.0017
460 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 347 0.0017
461 POOR QUALITY PRODUCT ADMINISTERED 18 0.0017
462 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
463 NYSTAGMUS 9 0.0017
464 DRUG INEFFECTIVE 2233 0.0017
465 EXTRA DOSE ADMINISTERED 68 0.0017
466 DYSGRAPHIA 11 0.0017
467 INJURY ASSOCIATED WITH DEVICE 34 0.0017
468 MOOD SWINGS 53 0.0017
469 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
470 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
471 MUSCLE FATIGUE 7 0.0017
472 MENINGITIS 11 0.0016
473 ELECTROCARDIOGRAM QT PROLONGED 59 0.0016
474 ASTHENOPIA 9 0.0016
475 WRONG TECHNIQUE IN DRUG USAGE PROCESS 59 0.0016
476 BLOOD GLUCOSE INCREASED 306 0.0016
477 CONJUNCTIVITIS 30 0.0016
478 HYPERACUSIS 6 0.0016
479 DIABETES MELLITUS 122 0.0016
480 IMPAIRED QUALITY OF LIFE 23 0.0016
481 AMNESIA 104 0.0016
482 BLOOD SODIUM DECREASED 30 0.0016
483 PANIC ATTACK 58 0.0016
484 DISORIENTATION 63 0.0016
485 HAIR GROWTH ABNORMAL 11 0.0016
486 BLOOD CHOLESTEROL INCREASED 74 0.0016
487 COORDINATION ABNORMAL 22 0.0016
488 EXPOSURE DURING PREGNANCY 98 0.0016
489 WHEELCHAIR USER 7 0.0016
490 NERVOUSNESS 82 0.0016
491 CRYING 57 0.0016
492 EXERCISE TOLERANCE DECREASED 9 0.0016
493 DEMENTIA 43 0.0015
494 HYPERTRIGLYCERIDAEMIA 9 0.0015
495 APLASTIC ANAEMIA 8 0.0015
496 MENSTRUATION IRREGULAR 41 0.0015
497 GAIT INABILITY 51 0.0015
498 FOOD CRAVING 8 0.0015
499 BLOOD LACTIC ACID INCREASED 8 0.0015
500 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
501 CEREBRAL ATROPHY 6 0.0015
502 QUALITY OF LIFE DECREASED 20 0.0015
503 VISION BLURRED 203 0.0015
504 HYPOAESTHESIA ORAL 22 0.0015
505 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
506 MENTAL STATUS CHANGES 40 0.0014
507 MALNUTRITION 16 0.0014
508 TEARFULNESS 6 0.0014
509 BLOOD URIC ACID INCREASED 8 0.0014
510 NEUTROPHIL COUNT INCREASED 14 0.0014
511 INITIAL INSOMNIA 14 0.0014
512 PRODUCT FORMULATION ISSUE 9 0.0014
513 APHONIA 19 0.0014
514 INJECTION SITE WARMTH 28 0.0014
515 ADVERSE REACTION 18 0.0014
516 CONFUSIONAL STATE 218 0.0013
517 FEELING DRUNK 10 0.0013
518 TERMINAL STATE 9 0.0013
519 HYPERGLYCAEMIA 49 0.0013
520 POLLAKIURIA 56 0.0013
521 CHOKING 26 0.0013
522 EMOTIONAL DISTRESS 161 0.0013
523 INTESTINAL OBSTRUCTION 50 0.0013
524 BODY TEMPERATURE INCREASED 27 0.0013
525 IMPAIRED DRIVING ABILITY 15 0.0013
526 ACTIVITIES OF DAILY LIVING IMPAIRED 26 0.0013
527 SLEEP APNOEA SYNDROME 25 0.0013
528 ENCEPHALOPATHY 32 0.0013
529 MEMORY IMPAIRMENT 179 0.0013
530 DRUG ABUSER 8 0.0013
531 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
532 NICOTINE DEPENDENCE 10 0.0013
533 MOOD ALTERED 35 0.0013
534 UNRESPONSIVE TO STIMULI 33 0.0013
535 FAECALOMA 7 0.0013
536 GAIT DISTURBANCE 243 0.0013
537 PRODUCT STORAGE ERROR 111 0.0013
538 LOSS OF CONSCIOUSNESS 162 0.0013
539 HEART RATE ABNORMAL 7 0.0013
540 HEPATIC CYTOLYSIS 16 0.0013
541 IMPAIRED GASTRIC EMPTYING 17 0.0012
542 PANIC REACTION 9 0.0012
543 DRUG DISPENSING ERROR 19 0.0012
544 EPILEPSY 38 0.0012
545 WEIGHT FLUCTUATION 13 0.0012
546 STATUS EPILEPTICUS 14 0.0012
547 DIZZINESS POSTURAL 12 0.0012
548 DYSPHAGIA 117 0.0012
549 HEART RATE INCREASED 122 0.0012
550 INCORRECT DOSAGE ADMINISTERED 6 0.0012
551 RENAL PAIN 13 0.0012
552 RENAL IMPAIRMENT 103 0.0012
553 POLYURIA 10 0.0012
554 PULMONARY EMBOLISM 116 0.0012
555 SOMNAMBULISM 8 0.0012
556 MASS 17 0.0012
557 HYPOTONIA 12 0.0012
558 PRODUCT LABEL CONFUSION 7 0.0012
559 URINARY RETENTION 40 0.0012
560 HEART RATE IRREGULAR 27 0.0012
561 PRODUCT DISPENSING ERROR 26 0.0012
562 ENERGY INCREASED 7 0.0012
563 ATAXIA 14 0.0012
564 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
565 DENTAL CARIES 13 0.0012
566 THERAPY CESSATION 60 0.0012
567 THYROID DISORDER 18 0.0012
568 PRODUCT CONTAINER ISSUE 10 0.0012
569 DRUG INTERACTION 183 0.0012
570 FORMICATION 8 0.0011
571 DEVICE ISSUE 102 0.0011
572 GRIP STRENGTH DECREASED 10 0.0011
573 ABSCESS 18 0.0011
574 MALAISE 492 0.0011
575 WITHDRAWAL SYNDROME 47 0.0011
576 SENSORY LOSS 9 0.0011
577 FRUSTRATION TOLERANCE DECREASED 9 0.0011
578 PHOTOPSIA 7 0.0011
579 HYPONATRAEMIA 62 0.0011
580 SLEEP DISORDER 77 0.0011
581 PHOTOSENSITIVITY REACTION 18 0.0011
582 INTESTINAL ISCHAEMIA 6 0.0011
583 BRAIN NEOPLASM 10 0.0011
584 SYNCOPE 108 0.0011
585 AGRANULOCYTOSIS 20 0.0011
586 DRY MOUTH 87 0.0011
587 DRUG USE DISORDER 9 0.0011
588 GLYCOSYLATED HAEMOGLOBIN INCREASED 27 0.0011
589 OVERDOSE 230 0.0011
590 PHOTOPHOBIA 20 0.0011
591 DEPRESSED LEVEL OF CONSCIOUSNESS 42 0.0011
592 PEMPHIGOID 8 0.0011
593 NEUTROPHILIA 6 0.0011
594 PRODUCT AVAILABILITY ISSUE 24 0.0011
595 BACK DISORDER 17 0.0010
596 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
597 HYPERVENTILATION 6 0.0010
598 INJECTION SITE HAEMATOMA 15 0.0010
599 CARDIOVASCULAR DISORDER 26 0.0010
600 PANCREATITIS ACUTE 23 0.0010
601 MUSCULAR WEAKNESS 116 0.0010
602 DRUG EFFECT INCOMPLETE 37 0.0010
603 HYPERHIDROSIS 130 0.0010
604 BLADDER DISORDER 10 0.0010
605 BLOOD PRESSURE ABNORMAL 20 0.0010
606 ACCIDENT 12 0.0010
607 MIOSIS 8 0.0010
608 HYPOAESTHESIA 149 0.0010
609 INJECTION SITE VESICLES 6 0.0010
610 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6 0.0010
611 TYPE 2 DIABETES MELLITUS 33 0.0010
612 LEUKOPENIA 48 0.0010
613 DIABETIC KETOACIDOSIS 23 0.0010
614 PALPITATIONS 112 0.0010
615 SWELLING FACE 62 0.0010
616 INJECTION SITE IRRITATION 12 0.0009
617 SCAR 16 0.0009
618 DISCOMFORT 57 0.0009
619 ARRHYTHMIA 44 0.0009
620 CONSTIPATION 202 0.0009
621 VITAMIN D DEFICIENCY 9 0.0009
622 MENSTRUATION DELAYED 10 0.0009
623 HYPERLIPIDAEMIA 11 0.0009
624 INJECTION SITE ERYTHEMA 114 0.0009
625 HAEMODYNAMIC INSTABILITY 7 0.0009
626 WEIGHT DECREASED 255 0.0009
627 HEPATIC STEATOSIS 17 0.0009
628 SARS-COV-2 TEST POSITIVE 12 0.0009
629 BLINDNESS 37 0.0009
630 PRODUCT COMPLAINT 23 0.0009
631 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
632 DIZZINESS 441 0.0009
633 DRY EYE 44 0.0009
634 JOINT STIFFNESS 23 0.0009
635 BLOOD DISORDER 7 0.0009
636 ANGINA PECTORIS 25 0.0009
637 DYSPHONIA 51 0.0009
638 ABNORMAL DREAMS 24 0.0009
639 HEPATIC ENZYME INCREASED 59 0.0009
640 NERVOUS SYSTEM DISORDER 27 0.0009
641 VISUAL IMPAIRMENT 107 0.0009
642 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61 0.0009
643 DRUG RESISTANCE 22 0.0009
644 HYPERAESTHESIA 7 0.0009
645 RASH GENERALISED 22 0.0008
646 TINNITUS 39 0.0008
647 DEEP VEIN THROMBOSIS 55 0.0008
648 THERMAL BURN 6 0.0008
649 HYPOTHYROIDISM 27 0.0008
650 CHEST PAIN 156 0.0008
651 FEELING JITTERY 16 0.0008
652 VISUAL FIELD DEFECT 6 0.0008
653 MYALGIA 141 0.0008
654 HYPERCHOLESTEROLAEMIA 8 0.0008
655 SINUS BRADYCARDIA 8 0.0008
656 HYPOPHAGIA 21 0.0008
657 HAEMORRHOIDS 16 0.0008
658 CARDIAC DISORDER 76 0.0008
659 DIPLOPIA 21 0.0008
660 C-REACTIVE PROTEIN INCREASED 29 0.0008
661 CELLULITIS 40 0.0008
662 FRACTURE 15 0.0008
663 HYPERTENSION 167 0.0008
664 BALANCE DISORDER 68 0.0008
665 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
666 INJURY 55 0.0008
667 COMA 37 0.0008
668 TENDONITIS 12 0.0008
669 WHITE BLOOD CELL COUNT DECREASED 83 0.0008
670 MULTIPLE ALLERGIES 6 0.0008
671 TOOTH DISORDER 17 0.0008
672 JOINT DISLOCATION 8 0.0008
673 SOPOR 10 0.0008
674 DYSSTASIA 22 0.0008
675 MUSCLE SPASMS 138 0.0008
676 UTERINE CANCER 6 0.0007
677 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
678 PRODUCT PHYSICAL ISSUE 15 0.0007
679 LIMB DISCOMFORT 23 0.0007
680 FEEDING DISORDER 15 0.0007
681 NEUTROPHIL COUNT DECREASED 30 0.0007
682 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
683 NEUTROPENIA 100 0.0007
684 PALLOR 20 0.0007
685 DEATH 632 0.0007
686 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
687 HICCUPS 6 0.0007
688 EYE DISORDER 24 0.0007
689 ILLNESS 75 0.0007
690 CYST 9 0.0007
691 FATIGUE 561 0.0007
692 INJECTION SITE DISCOLOURATION 9 0.0007
693 TOOTHACHE 13 0.0007
694 FEELING HOT 44 0.0007
695 BRADYCARDIA 38 0.0007
696 SKIN REACTION 10 0.0007
697 HYPOTENSION 142 0.0007
698 DIALYSIS 10 0.0007
699 RESPIRATORY DISORDER 21 0.0007
700 NEOPLASM 8 0.0007
701 HEAD INJURY 22 0.0007
702 MUSCLE STRAIN 6 0.0007
703 DEVICE DEFECTIVE 12 0.0007
704 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
705 EYELID PTOSIS 7 0.0007
706 BONE PAIN 40 0.0007
707 CARDIOMYOPATHY 10 0.0007
708 PAIN IN EXTREMITY 199 0.0007
709 GLAUCOMA 13 0.0007
710 VENTRICULAR EXTRASYSTOLES 7 0.0007
711 EYE DISCHARGE 7 0.0007
712 HAIR TEXTURE ABNORMAL 9 0.0007
713 TENDERNESS 7 0.0007
714 EAR PAIN 13 0.0007
715 SCRATCH 7 0.0007
716 LEUKOCYTOSIS 12 0.0007
717 LIP SWELLING 22 0.0007
718 ACCIDENTAL OVERDOSE 24 0.0007
719 HYPERSENSITIVITY 121 0.0007
720 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
721 PHARYNGEAL OEDEMA 10 0.0006
722 DECREASED ACTIVITY 7 0.0006
723 ABASIA 16 0.0006
724 ROAD TRAFFIC ACCIDENT 27 0.0006
725 ASTHENIA 242 0.0006
726 PULMONARY THROMBOSIS 7 0.0006
727 LACERATION 6 0.0006
728 CYANOSIS 10 0.0006
729 THROMBOSIS 51 0.0006
730 BRAIN OEDEMA 8 0.0006
731 LOCAL SWELLING 11 0.0006
732 CARDIAC ARREST 52 0.0006
733 LACRIMATION INCREASED 19 0.0006
734 INTENTIONAL OVERDOSE 40 0.0006
735 MYDRIASIS 8 0.0006
736 DECREASED APPETITE 143 0.0006
737 DEAFNESS 16 0.0006
738 HEPATOMEGALY 6 0.0006
739 PERIPHERAL SWELLING 94 0.0006
740 ELECTROLYTE IMBALANCE 7 0.0006
741 BLOOD POTASSIUM DECREASED 18 0.0006
742 SWELLING 56 0.0006
743 DYSURIA 22 0.0006
744 BLOOD GLUCOSE ABNORMAL 11 0.0006
745 UNEVALUABLE EVENT 45 0.0006
746 BLOOD PRESSURE DECREASED 39 0.0006
747 LIVER DISORDER 26 0.0006
748 MOBILITY DECREASED 42 0.0006
749 MUSCULOSKELETAL CHEST PAIN 9 0.0006
750 RENAL DISORDER 27 0.0006
751 PNEUMONIA 187 0.0006
752 FALL 191 0.0006
753 INCORRECT DOSE ADMINISTERED BY DEVICE 15 0.0006
754 SKIN DISORDER 19 0.0006
755 DRUG INTOLERANCE 55 0.0006
756 HEADACHE 350 0.0006
757 EYE IRRITATION 32 0.0006
758 PANCREATITIS 29 0.0005
759 GASTROENTERITIS 8 0.0005
760 BLOOD GLUCOSE FLUCTUATION 6 0.0005
761 ANGIOEDEMA 24 0.0005
762 DEHYDRATION 72 0.0005
763 HYPERTENSIVE CRISIS 6 0.0005
764 PULMONARY CONGESTION 7 0.0005
765 MUSCULOSKELETAL DISORDER 10 0.0005
766 PNEUMONIA ASPIRATION 13 0.0005
767 NECK PAIN 29 0.0005
768 TACHYPNOEA 7 0.0005
769 THERAPY NON-RESPONDER 23 0.0005
770 MYOCLONUS 6 0.0005
771 SKIN DISCOLOURATION 23 0.0005
772 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
773 BLOOD PRESSURE INCREASED 76 0.0005
774 HEPATITIS C 6 0.0005
775 MUSCULOSKELETAL PAIN 26 0.0005
776 DYSPNOEA 280 0.0005
777 NOCTURIA 6 0.0005
778 LACTIC ACIDOSIS 16 0.0005
779 ALOPECIA 97 0.0005
780 LIVER FUNCTION TEST ABNORMAL 14 0.0005
781 INJECTION SITE PRURITUS 32 0.0005
782 MYOCARDIAL INFARCTION 83 0.0005
783 HAEMATEMESIS 12 0.0005
784 DRUG WITHDRAWAL SYNDROME NEONATAL 7 0.0005
785 ACUTE RESPIRATORY FAILURE 9 0.0005
786 LIVER FUNCTION TEST INCREASED 10 0.0005
787 PRESCRIBED OVERDOSE 9 0.0005
788 PARAESTHESIA 73 0.0005
789 OXYGEN SATURATION DECREASED 26 0.0005
790 ECONOMIC PROBLEM 7 0.0005
791 INFLUENZA LIKE ILLNESS 38 0.0005
792 VOMITING 217 0.0005
793 PLATELET COUNT INCREASED 6 0.0005
794 MENORRHAGIA 9 0.0005
795 GASTROINTESTINAL DISORDER 41 0.0005
796 BURNING SENSATION 32 0.0005
797 HEART RATE DECREASED 16 0.0005
798 COLD SWEAT 8 0.0005
799 DYSMENORRHOEA 6 0.0005
800 FIBROMYALGIA 11 0.0005
801 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
802 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
803 OEDEMA PERIPHERAL 55 0.0005
804 MIGRAINE 43 0.0004
805 PAIN 276 0.0004
806 CEREBROVASCULAR ACCIDENT 76 0.0004
807 INTENTIONAL PRODUCT MISUSE 39 0.0004
808 THROAT TIGHTNESS 12 0.0004
809 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
810 RASH 192 0.0004
811 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
812 FEELING COLD 12 0.0004
813 EYE SWELLING 16 0.0004
814 CHEST DISCOMFORT 44 0.0004
815 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
816 MIDDLE INSOMNIA 8 0.0004
817 EPISTAXIS 32 0.0004
818 BLOOD TEST ABNORMAL 6 0.0004
819 SURGERY 25 0.0004
820 INJECTION SITE HAEMORRHAGE 34 0.0004
821 CONVULSION 24 0.0004
822 NEOPLASM MALIGNANT 28 0.0004
823 ANAPHYLACTIC REACTION 23 0.0004
824 PYREXIA 144 0.0004
825 HYPERTHYROIDISM 6 0.0004
826 HERNIA 8 0.0004
827 PRODUCT PRESCRIBING ISSUE 9 0.0004
828 PRESYNCOPE 10 0.0004
829 ACNE 31 0.0004
830 EYE PAIN 23 0.0004
831 INFLAMMATION 21 0.0004
832 METABOLIC ACIDOSIS 13 0.0004
833 OEDEMA 22 0.0004
834 TRANSAMINASES INCREASED 9 0.0004
835 NIGHT SWEATS 13 0.0004
836 RHINORRHOEA 26 0.0004
837 UPPER LIMB FRACTURE 8 0.0004
838 ECZEMA 21 0.0004
839 SNEEZING 9 0.0004
840 URTICARIA 67 0.0004
841 BREAST CANCER 37 0.0004
842 LYMPHADENOPATHY 14 0.0004
843 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
844 HYPOACUSIS 17 0.0004
845 TREATMENT FAILURE 32 0.0004
846 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
847 RED BLOOD CELL COUNT DECREASED 11 0.0004
848 CONTUSION 37 0.0004
849 BACK PAIN 89 0.0004
850 SCIATICA 6 0.0004
851 EAR INFECTION 10 0.0004
852 ABDOMINAL DISTENSION 39 0.0004
853 HYPOGLYCAEMIA 18 0.0004
854 NEURALGIA 9 0.0004
855 DEVICE BREAKAGE 15 0.0004
856 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
857 RENAL FAILURE 49 0.0004
858 FAECES DISCOLOURED 8 0.0004
859 LIMB INJURY 10 0.0004
860 ACUTE HEPATIC FAILURE 5 0.0004
861 INTENTIONAL PRODUCT USE ISSUE 32 0.0004
862 MULTIPLE FRACTURES 6 0.0004
863 INJECTION SITE BRUISING 29 0.0004
864 RESPIRATORY ARREST 10 0.0004
865 NASAL CONGESTION 21 0.0004
866 PERICARDITIS 6 0.0004
867 BLISTER 20 0.0004
868 FACE OEDEMA 6 0.0004
869 CHROMATURIA 8 0.0004
870 ABORTION SPONTANEOUS 14 0.0003
871 EOSINOPHILIA 6 0.0003
872 GASTRITIS 9 0.0003
873 GALLBLADDER DISORDER 6 0.0003
874 CATARACT 20 0.0003
875 CHOLELITHIASIS 11 0.0003
876 BLOOD PRESSURE FLUCTUATION 8 0.0003
877 RETCHING 7 0.0003
878 VERTIGO 20 0.0003
879 SKIN LESION 9 0.0003
880 LIVER INJURY 8 0.0003
881 THROMBOCYTOPENIA 36 0.0003
882 ACUTE KIDNEY INJURY 49 0.0003
883 APPLICATION SITE PAIN 7 0.0003
884 URINARY TRACT INFECTION 54 0.0003
885 OCULAR HYPERAEMIA 15 0.0003
886 TOXICITY TO VARIOUS AGENTS 53 0.0003
887 INFLUENZA 35 0.0003
888 HEPATITIS 8 0.0003
889 CARDIAC FAILURE 25 0.0003
890 ANAPHYLACTIC SHOCK 8 0.0003
891 HAEMATOMA 8 0.0003
892 HAEMATOCHEZIA 17 0.0003
893 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
894 HYPOKALAEMIA 14 0.0003
895 FLATULENCE 17 0.0003
896 SEPTIC SHOCK 13 0.0003
897 BLOOD BILIRUBIN INCREASED 8 0.0003
898 FLUID RETENTION 15 0.0003
899 GASTRIC DISORDER 10 0.0003
900 PLATELET COUNT DECREASED 31 0.0003
901 CHILLS 34 0.0003
902 COVID-19 50 0.0003
903 NAUSEA 224 0.0003
904 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
905 ABDOMINAL PAIN UPPER 58 0.0003
906 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
907 JOINT INJURY 6 0.0003
908 AGEUSIA 7 0.0003
909 PRURITUS GENERALISED 6 0.0003
910 VAGINAL HAEMORRHAGE 12 0.0003
911 DISEASE RECURRENCE 13 0.0003
912 STAPHYLOCOCCAL INFECTION 9 0.0003
913 OROPHARYNGEAL PAIN 25 0.0003
914 FUNGAL INFECTION 9 0.0003
915 ARTHRALGIA 112 0.0003
916 RESPIRATORY TRACT INFECTION 7 0.0003
917 CARDIO-RESPIRATORY ARREST 11 0.0003
918 SHOCK 6 0.0003
919 RASH PRURITIC 14 0.0003
920 PRURITUS 99 0.0003
921 RESPIRATORY DISTRESS 7 0.0003
922 PSORIASIS 33 0.0003
923 ARTHROPATHY 14 0.0003
924 CYSTITIS 8 0.0003
925 INFECTION 36 0.0002
926 ILL-DEFINED DISORDER 15 0.0002
927 INJECTION SITE URTICARIA 6 0.0002
928 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
929 VIRAL INFECTION 8 0.0002
930 LABORATORY TEST ABNORMAL 7 0.0002
931 PREMATURE BABY 7 0.0002
932 DIARRHOEA 150 0.0002
933 HEPATIC FAILURE 7 0.0002
934 BLOOD GLUCOSE DECREASED 11 0.0002
935 ERYTHEMA 47 0.0002
936 THERAPY INTERRUPTED 16 0.0002
937 HAEMORRHAGE 23 0.0002
938 OSTEOPOROSIS 9 0.0002
939 WOUND 6 0.0002
940 ABDOMINAL DISCOMFORT 36 0.0002
941 HEPATIC FUNCTION ABNORMAL 8 0.0002
942 HAEMOGLOBIN DECREASED 22 0.0002
943 DYSPEPSIA 21 0.0002
944 SKIN BURNING SENSATION 15 0.0002
945 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
946 RESPIRATORY FAILURE 15 0.0002
947 ARTHRITIS 16 0.0002
948 ABDOMINAL PAIN 47 0.0002
949 DEPENDENCE 11 0.0002
950 RASH MACULAR 7 0.0002
951 NEUROPATHY PERIPHERAL 19 0.0002
952 COUGH 56 0.0002
953 BLOOD CREATININE INCREASED 13 0.0002
954 HYPOXIA 7 0.0002
955 PANCYTOPENIA 11 0.0002
956 CEREBRAL HAEMORRHAGE 7 0.0002
957 ATRIAL FIBRILLATION 19 0.0002
958 FEMUR FRACTURE 6 0.0002
959 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
960 ANAEMIA 35 0.0002
961 PLEURAL EFFUSION 11 0.0002
962 DRUG DEPENDENCE 29 0.0002
963 DRY SKIN 24 0.0002
964 NEPHROLITHIASIS 8 0.0002
965 HOT FLUSH 13 0.0002
966 SEPSIS 19 0.0002
967 FLUSHING 17 0.0002
968 JOINT SWELLING 20 0.0002
969 NASOPHARYNGITIS 30 0.0002
970 DYSGEUSIA 12 0.0002
971 DISEASE PROGRESSION 19 0.0002
972 PRODUCT SUBSTITUTION ISSUE 9 0.0002
973 PULMONARY OEDEMA 7 0.0002
974 SKIN IRRITATION 7 0.0002
975 CARDIAC FAILURE CONGESTIVE 12 0.0001
976 PRODUCTIVE COUGH 7 0.0001
977 MULTIPLE SCLEROSIS 7 0.0001
978 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
979 LUNG DISORDER 7 0.0001
980 SKIN EXFOLIATION 12 0.0001
981 WHEEZING 8 0.0001
982 THROAT IRRITATION 6 0.0001
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
984 RASH ERYTHEMATOUS 6 0.0001
985 DRUG WITHDRAWAL SYNDROME 11 0.0001
986 ASTHMA 14 0.0001
987 SINUSITIS 11 0.0001
988 BRONCHITIS 7 0.0001
989 CHRONIC KIDNEY DISEASE 7 0.0001
990 NO ADVERSE EVENT 11 0.0001